Alphatec Holdings (ATEC) stock plummeted 5.06% in the pre-market trading session on Thursday, following the company's fourth-quarter 2024 earnings call where it provided guidance for the upcoming year.
During the earnings call, Alphatec projected revenue growth of 20% for 2025, which came in lower than analysts' expectations. The company forecasted revenue of approximately $732 million for the year, including surgical revenue growth of 21% to around $657 million.
While Alphatec reported strong fourth-quarter results, with revenue growing 28% year-over-year and adjusted EBITDA reaching $21 million, investors seemed concerned about the company's outlook for the coming year. The projected revenue growth rate of 20% was viewed as disappointing, especially in light of the company's recent performance and the disruptions in the spine surgery market.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。